Fig. 1
From: Effects of 17β-estradiol and equilin on atherosclerosis development in female Apoeshl mice
(A) Schematic illustration of the study protocol. (B,C); Body weight and uterine weight of mice at 18 weeks of age. (B) Comparison of body weight between the placebo (solid line), equilin (Eq; center line), and 17β-estradiol (E2; dashed line) groups. (C) Comparison of uterine weight between the placebo (solid bars), Eq (dotted bars), and E2 groups (open bars). *p < 0.01; n.s., not significant. (D–I); Lipoprotein profile of the serum of mice treated with placebo, equilin (Eq), or 17β-estradiol (E2). (D) Total cholesterol, (E) very-low-density lipoprotein (VLDL), (F) LDL, (G) high-density lipoprotein (HDL), (H) triglyceride, and (I) chylomicron levels. Solid bars indicate placebo, dotted bars indicate Eq, and open bars indicate E2.
